Stay updated on Pembrolizumab in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Multiple Myeloma Clinical Trial page.

Latest updates to the Pembrolizumab in Multiple Myeloma Clinical Trial page
- Check4 days agoChange DetectedThe related topics area now includes 'Multiple myeloma' and a 'MedlinePlus Genetics' link, and the revision tag was updated to v3.6.3 from v3.6.2.SummaryDifference0.2%

- Check11 days agoChange DetectedAdded 'Revision: v3.6.2' in the page footer and removed specific related topics entries (e.g., 'Multiple myeloma' and 'MedlinePlus Genetics'), along with deleting the older 'Revision: v3.6.0' text.SummaryDifference0.2%

- Check18 days agoChange DetectedThe page now includes additional related topic entries, specifically listing Multiple myeloma and linking to MedlinePlus Genetics under the related topics section, expanding access to disease information within the study context.SummaryDifference0.2%

- Check25 days agoChange DetectedAdds a recruitment status note ('No longer looking for participants') and new help/navigation items ('How to Read a Study Record', 'Common Questions', 'How to Join a Study') along with an updated revision tag (Revision: v3.6.0). It also removes older topics and sections ('Intervention / Treatment', 'Multiple myeloma', MedlinePlus Genetics, and the prior revision tag Revision: v3.5.5).SummaryDifference0.7%

- Check33 days agoChange DetectedThe page revision label changed from v3.5.4 to v3.5.5, signaling a minor update to the page version without altering trial details.SummaryDifference0.1%

- Check40 days agoChange DetectedAdded related topic entries under the MedlinePlus related topics section. Specifically lists 'Multiple myeloma' and 'MedlinePlus Genetics'.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Multiple Myeloma Clinical Trial page.